Supervised injection sites are healthcare facilities where people can use pre-obtained drugs under medical watch, primarily to prevent fatal overdoses. Staff do not provide or administer illegal drugs. Instead, they offer clean supplies, monitor for emergencies, and connect visitors with health and social services. These facilities operate in over a dozen countries and have become one of the most studied, and most debated, harm reduction strategies in the world.
How a Visit Works
A person arrives at the facility with drugs they already have. They check in, receive sterile injection supplies, and move to a supervised consumption area where they use their substance at their own pace. A nurse is typically present throughout, watching for signs of overdose or severe allergic reaction and ready to intervene immediately if something goes wrong. After injecting, visitors move to a recovery area where they’re monitored until the acute effects subside.
Nurses serve as the primary point of contact. Their role includes assessing each person’s knowledge of safer injection practices, providing education on reducing harm, and stepping in during medical emergencies. They do not handle or administer any illegal substances a person brings in. Beyond the immediate visit, nurses and peer support workers can make referrals to addiction treatment, primary care, housing assistance, food programs, and income support.
Overdose Prevention
The core purpose of these sites is keeping people alive. Roughly one overdose occurs per 1,000 injections at supervised facilities, and no fatal overdose has ever been reported inside one. That track record spans decades and multiple countries.
The impact extends beyond the facility walls. After Vancouver’s Insite opened in 2003 as North America’s first sanctioned site, overdose deaths among people living within 500 meters dropped from 253 to 165 per 100,000 person-years, a reduction of 88 deaths. That translates to roughly one life saved for every 1,137 people who used the site annually. The rest of the city saw no comparable change during the same period. Ambulance calls for overdose treatment in the surrounding area fell by 67%.
Reducing HIV and Hepatitis C
Sharing needles is one of the primary ways HIV and hepatitis C spread among people who inject drugs. Supervised sites attack this problem directly by providing sterile equipment and teaching safer practices. One U.S. study found that people who used a supervised consumption site were 83% less likely to share syringes than those who injected elsewhere. Canadian research has shown a consistent 70% reduction in syringe-sharing risk among site users.
Modeling research across three California counties estimated that if 20% of people who inject drugs used a supervised site, roughly 22% of new HIV infections and 28% of new hepatitis C infections could be prevented over ten years. In San Diego County, the projected reduction in new HIV cases was even higher, around 32% over a decade.
Effects on Surrounding Neighborhoods
One of the most common objections to supervised injection sites is that they’ll attract drug use, crime, and discarded needles to a neighborhood. The research consistently shows the opposite. A systematic review examining seven studies on crime and public nuisance found no increase in either category, and several studies documented reductions.
After Vancouver’s Insite opened, researchers measured significant drops in public injection, discarded syringes, and injection-related litter in the surrounding area. Over a five-year period, fewer residents and business owners reported witnessing public drug use or finding needles on the street. Frequent site users were significantly less likely to inject in public and significantly more likely to dispose of syringes safely. One important nuance: public injection was least likely when the facility had no wait time, suggesting that capacity matters. If a site is too small or too crowded to serve the local population, some of the neighborhood benefits diminish.
Connecting People to Treatment
Supervised sites are not treatment programs, but they often function as the first point of contact between someone using drugs and the healthcare system. About one-third of site users receive referrals to external services like addiction treatment, medical care, or social support, a rate that’s been remarkably consistent across studies in both North America and Australia. Of those referred, roughly 65% follow through and access the service.
The type of facility matters. Sites embedded within community health centers, where people can see a doctor or counselor in the same building, tend to produce higher rates of referral uptake than standalone harm reduction sites. The smaller client volume and integrated care model give staff more opportunities to build relationships and follow up with individuals over time.
Healthcare Cost Savings
Every overdose managed inside a supervised site is one that doesn’t require an ambulance and an emergency room visit. In Alberta, Canada, researchers calculated that each overdose reversed on-site saves approximately $1,600 CAD by avoiding the $385 ambulance transport and $1,061 emergency department visit. One facility alone saved over $2.3 million in emergency service costs over its operating life. That estimate is conservative because it excludes the cost of hospital admissions for more severe overdose cases. The same site prevented an estimated 700 ambulance calls per year, freeing up emergency services for other community needs.
Where They Operate
Supervised injection sites have operated in countries across Europe, as well as in Canada and Australia, for decades. Vancouver’s Insite has been open since 2003 and remains the most studied facility in North America.
In the United States, the legal picture is complicated. Federal law, specifically the Controlled Substances Act, makes it illegal to maintain a place for the purpose of using controlled substances. In 2024, a federal appeals court ruled that a proposed site in Philadelphia called Safehouse would violate this law and stated that only Congress can change the statute to allow such facilities. That ruling applies only within Pennsylvania, New Jersey, and Delaware, leaving the broader legal question unresolved nationally.
Despite this federal ambiguity, New York City authorized two supervised consumption sites in 2021, becoming the first U.S. city to do so. Both remain open. Rhode Island’s state legislature also authorized a pilot program in 2021, and its first site opened in December 2024. These facilities operate under local and state authorization, though the tension with federal law remains a live issue. Safehouse has filed another appeal, and the Supreme Court has so far declined to weigh in.